Flourish Research Acquires Diablo Clinical Research

Flourish Research, a multi-site clinical trial organization headquartered in Apex, North Carolina, has acquired Diablo Clinical Research, a Walnut Creek, California-based clinical research facility established in 1995 that has conducted more than 1,000 phase I–IV trials and medical device studies. The add-on acquisition (Flourish is PE-backed by Genstar Capital) expands Flourish's geographic footprint and therapeutic-area capabilities, particularly in endocrinology, cardiovascular and metabolic research.